CA2029537A1 - Derives de la pradimicine - Google Patents

Derives de la pradimicine

Info

Publication number
CA2029537A1
CA2029537A1 CA2029537A CA2029537A CA2029537A1 CA 2029537 A1 CA2029537 A1 CA 2029537A1 CA 2029537 A CA2029537 A CA 2029537A CA 2029537 A CA2029537 A CA 2029537A CA 2029537 A1 CA2029537 A1 CA 2029537A1
Authority
CA
Canada
Prior art keywords
group
alkenyl
methyl
substituted
alkylcarbamyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2029537A
Other languages
English (en)
Other versions
CA2029537C (fr
Inventor
Hajime Kamachi
Seiji Iimura
Satsuki Okuyama
Shimpei Aburaki
Takayuki Naito
Yasutsugu Ueda
Leonard B. Crast, Jr.
Amarendra B. Mikkilineni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CA2029537A1 publication Critical patent/CA2029537A1/fr
Application granted granted Critical
Publication of CA2029537C publication Critical patent/CA2029537C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/244Anthraquinone radicals, e.g. sennosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Cephalosporin Compounds (AREA)
CA002029537A 1989-11-14 1990-11-14 Derives de la pradimicine Expired - Fee Related CA2029537C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43650589A 1989-11-14 1989-11-14
US436,505 1990-11-14

Publications (2)

Publication Number Publication Date
CA2029537A1 true CA2029537A1 (fr) 1992-05-15
CA2029537C CA2029537C (fr) 2000-01-04

Family

ID=23732687

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002029537A Expired - Fee Related CA2029537C (fr) 1989-11-14 1990-11-14 Derives de la pradimicine

Country Status (15)

Country Link
EP (1) EP0428132B1 (fr)
JP (1) JP3010308B2 (fr)
KR (1) KR970000527B1 (fr)
AT (1) ATE92496T1 (fr)
AU (1) AU629713B2 (fr)
CA (1) CA2029537C (fr)
CY (1) CY1850A (fr)
DE (1) DE69002586T2 (fr)
DK (1) DK0428132T3 (fr)
ES (1) ES2058729T3 (fr)
FI (1) FI92207C (fr)
HK (1) HK110195A (fr)
IE (1) IE64609B1 (fr)
PT (1) PT95881B (fr)
ZA (1) ZA909101B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2643404B2 (ja) * 1989-01-13 1997-08-20 財団法人微生物化学研究会 新抗生物質n―アセチルベナノマイシンbならびにその製造法
CA2068484A1 (fr) * 1991-05-29 1992-11-30 Osamu Tenmyo Antibiotiques de pradimicine s
US5338728A (en) * 1992-08-14 1994-08-16 Bristol-Myers Squibb Pradimicin compounds
GB0306756D0 (en) * 2003-03-24 2003-04-30 Xzillion Gmbh & Co Kg Mass labels
KR101681686B1 (ko) * 2015-01-20 2016-12-01 김종원 고체풀 뚜껑

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870165A (en) * 1987-02-02 1989-09-26 Bristol-Myers Company Antifungal antibiotics
US5055453A (en) * 1987-11-02 1991-10-08 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Benanomicins a and antibiotic compositions
US4960755A (en) * 1988-07-19 1990-10-02 Bristol-Myers Company BU-3608 derivatives
US4973673A (en) * 1988-11-10 1990-11-27 Bristol-Myers Company Serine analogs of BU-3608 antibiotics

Also Published As

Publication number Publication date
CY1850A (en) 1996-03-08
DK0428132T3 (da) 1993-10-11
AU6653390A (en) 1991-05-23
PT95881A (pt) 1991-09-13
KR910009718A (ko) 1991-06-28
FI92207B (fi) 1994-06-30
DE69002586D1 (de) 1993-09-09
ZA909101B (en) 1991-07-31
IE904092A1 (en) 1991-05-22
ATE92496T1 (de) 1993-08-15
ES2058729T3 (es) 1994-11-01
PT95881B (pt) 1997-11-28
CA2029537C (fr) 2000-01-04
DE69002586T2 (de) 1994-01-13
FI905559A0 (fi) 1990-11-09
HK110195A (en) 1995-07-14
JPH03170492A (ja) 1991-07-24
AU629713B2 (en) 1992-10-08
JP3010308B2 (ja) 2000-02-21
EP0428132B1 (fr) 1993-08-04
KR970000527B1 (ko) 1997-01-13
IE64609B1 (en) 1995-08-23
FI92207C (fi) 1994-10-10
EP0428132A1 (fr) 1991-05-22

Similar Documents

Publication Publication Date Title
AU588890B2 (en) (4-Piperidinylmethyl and - hetero) Purines
FI900085A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(pyrimidin- ja kondensoitu pyrimidin-4-oni)etyyli-piperidiini- ja piperatsiinijohdannaisten valmistamiseksi
DE68925223D1 (de) 3-Alkenyl-1-azabicyclo(3.2.0)hept-2-en-2-carbonsäure-Verbindungen
IL109615A0 (en) Polypeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
DK96786D0 (da) Aminosyrederivater
IE892535L (en) Antipsychotic 3-piperazinylbenzazole derivatives
AU3583989A (en) New cephem compounds and processes for preparation thereof
AU629713B2 (en) Pradimicin derivatives
PT92147A (pt) Processo para a preparacao de derivados de pirrolidina
MX9202845A (es) Derivado de pradimicina.
EP0573659A4 (en) Pyrazolothiazolopyrimidine derivative
ES2061579T3 (es) Compuestos cefem y procedimientos para su preparacion.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed